About Us

Increasing patient access to new drugs and devices through clinical trials.

The Investigational Medicine Unit (IMU) was established to lead and facilitate investigational medicine research within NUHS through collaborations with academics and industry partners to translate laboratory discoveries.

It facilitates and conducts high quality clinical trials to enable patient access to novel therapeutics and technology. IMU’s focus is on early phase clinical trials which includes Proof of Concept, Phase 1 and Phase 2 studies. It also supports Phase 3 and Phase 4 studies, biomarker research as well as bio-imaging analysis.

Source: http://nuhs.edu.sg/research/useful-resources.html

History of IMU

  • 1997

    Label

    1997

    Set up of Clinical Trials Unit (CTU) to support clinical trials conducting in National University hospital (NUH).

    • Provide ICH-GCP compliant clinical trial infrastructure for investigators.
    • Provide a one-stop, seamless contact centre for pharmaceutical companies interested in developing and testing new compounds.
    • Support training programmes for clinical trial management.
  • 2006

    Label

    2006

    Successfully completed first First-in-Man H5N1 Vaccine (810501) Industry Sponsored Clinical Trial.

  • 2009

    Label

    2009

    CTU renamed as Investigational Medicine Unit (IMU) and focused on developing capabilities and experiences in early-phase clinical trials.

  • 2011

    Label

    2011

    • IMU participated in the largest Investigator Initiated Clinical Trial of 1,500 Subjects using an online recruitment portal – The CHIP Trial
  • 2012

    2012

      • IMU relocated from National Hospital University (NUH) Kent Ridge Wing to Centre for Translational Medicine (CeTM).
  • 2016

    Label

    2016

    The first Principal Investigator initiated, made-in-Singapore oral anti-diabetic drug clinical trial (DAA-I) conducted in IMU.

    This is the first public (NMRC) funded “Made in Singapore” drug to have completed the Phase 1 study in NUHS IMU (Singapore).

Our Team

Prof. Goh Boon Cher

DIRECTOR

Dr. Stephanie Tan

DEPUTY DIRECTOR

Clinical Operations

Tan Tek Seng

ASSISTANT DIRECTOR

Joanna Chang

SENIOR MANAGER

Process Optimization

Te Ye

ASSISTANT MANAGER

Proposal

Erdei Katalin Sarolta

ASSISTANT MANAGER

Feasibility

Jessica Lee

ASSISTANT MANAGER

Biostatistics

Prof Tai Bee Choo

BIOSTATISTICIAN

Chen Zhao Jin

BIOSTATISTICIAN

Corporate Communications

Aaron Shen Junwei

COMMUNICATION DESIGN LEAD

Billing, Finance & Facilities Management

Shermaine Kwan

ASSISTANT MANAGER

Toh E-Ling

SENIOR EXECUTIVE ASSISTANT

Esther Ong

SENIOR EXECUTIVE ASSISTANT

Clinical Research Coordinator

Grace Xie Chunxia

Joanna Kan Zheng Wen

Joshua Ng Hui

Evangeline Pow

Yoong Kai Shen

Matthew Lim

Rachael Ho

Intan Permata Sari

Yu Bu Duo

Serene Lai Xin Hui

Michel Leong

Aaron Shen Junwei

Shaileen Ng

Vithya D/O A Asogan

Yusof Bin Ibrahim